Overview

A Study of Adalimumab to Treat Sarcoidosis of the Skin

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if adalimumab is an effective for the skin manifestations of sarcoidosis.
Phase:
Phase 2
Details
Lead Sponsor:
Pariser, Robert J., M.D.
Collaborators:
Abbott
Virginia Clinical Research, Inc.
Treatments:
Adalimumab